NSCI.F Stock Overview
Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Nanalysis Scientific Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.29 |
| 52 Week High | CA$0.45 |
| 52 Week Low | CA$0.24 |
| Beta | 0.74 |
| 11 Month Change | -10.33% |
| 3 Month Change | -6.83% |
| 1 Year Change | -25.09% |
| 33 Year Change | -71.87% |
| 5 Year Change | n/a |
| Change since IPO | -25.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| NSCI.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.9% | -0.6% | 0.9% |
| 1Y | -25.1% | 20.8% | 32.3% |
Return vs Industry: NSCI.F underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: NSCI.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| NSCI.F volatility | |
|---|---|
| NSCI.F Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: NSCI.F has not had significant price volatility in the past 3 months.
Volatility Over Time: NSCI.F's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 249 | Sean Krakiwsky | www.nanalysis.com |
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching.
Nanalysis Scientific Corp. Fundamentals Summary
| NSCI.F fundamental statistics | |
|---|---|
| Market cap | US$31.80m |
| Earnings (TTM) | -US$9.56m |
| Revenue (TTM) | US$29.20m |
1.1x
P/S Ratio-3.3x
P/E RatioIs NSCI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSCI.F income statement (TTM) | |
|---|---|
| Revenue | CA$39.47m |
| Cost of Revenue | CA$30.63m |
| Gross Profit | CA$8.84m |
| Other Expenses | CA$21.77m |
| Earnings | -CA$12.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 22.40% |
| Net Profit Margin | -32.75% |
| Debt/Equity Ratio | 61.0% |
How did NSCI.F perform over the long term?
See historical performance and comparison